The Patent Finder

ONCOC4, Inc.

Also on record
Records under this name other than the patents ONCOC4, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 5 of 5 · Back to ONCOC4, Inc.

PatentTitleStatus Expires Confidence
US 11,629,188Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,261,233CD80 and CD86 binding protein compositions and uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,129,299Mutant ANTI-CTLA-4 Antibodies with Improved Immunotherapeutic Effect But Attenuated Adverse Effects
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,877,998Uses of hypoxia-inducible factor inhibitors
Formerly held
Lapsed on the fee record
Ended Jan 30, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 30, 2026From the USPTO record
US 9,623,070Uses of hypoxia-inducible factor inhibitors
Lapsed on the fee record
Ended Apr 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited